-
Prestige Brands: Fiscal 2013 focus on driving core OTC growth
IRVINGTON, N.Y. — Prestige Brands closed out its fiscal 2012 ended March 31 on a high note with $441.1 million in revenues for the year, up 31.1%. And fiscal 2013 is looking promising as the company will have full-year contributions from its 17 acquired over-the-counter brands from GlaxoSmithKline.
-
Prestige Brands highlights new Dramamine for Kids product in fiscal 2012 call
IRVINGTON, N.Y. — Prestige Brands on Thursday morning announced the launch of Dramamine for Kids, noting that 34% of households (with children between the ages of 2 years and 12 years) have a child with motion sickness. According to the company, it is estimated that one-third of moms currently are using a Dramamine adult formula but would prefer a pediatric product.